Sri Lankan Court bans former President Gotabaya Rajapaksa from overseas travel in Easter attacks probe, Germany scraps airport transit visa requirement for Indians, India to gradually replace WPI with Producer Price Index, Govt notifies two new special economic zones in Puducherry,

Govt approves Corbevax and Covovax vaccines

In India two more ant covid vaccines have been given emergency approval. The Central Drugs Standard Control Organisation has given approval to Corbevax vaccine, Covovax vaccine and anti-viral drug Molnupiravir for restricted use in emergency situations. In a series of tweets, Union Health Minister Mansukh Mandaviya said, Corbevax vaccine is India's first indigenously developed RBD protein sub-unit vaccine against COVID-19, made by Hyderabad-based firm Biological-E. It is the third vaccine developed in India.  

The Nanoparticle Vaccine, Covovax, will be manufactured by Pune-based firm Serum Institute of India. Mandaviya said, Molnupiravir will now be manufactured in the country by 13 companies for restricted use under emergency situation for treatment of adult patients with COVID-19 and who have high risk of progression of the disease.


Newsinc24 is now on telegram. Click here to join our channel @newsinc24 and stay updated with the latest news from politics, entertainment and other fields.

Food & Lifestyle

Avocado is also an excellent source of dietary fiber. Including it in your meals can contribute significantly to your daily fiber intake. 

Read More

Crime

CBI on Tuesday filed three chargesheets in connection with the alleged misappropriation of funds belonging to the KMVSTDCL..

Read More

Opinion

Let the imagination continue so that you, the reader, can experience the pain I am going through.

Read More

Credibility Matters at Newsinc24.com because it is a website that gives you fast and accurate news coverage. It provides news related to politics, astrotalk, business, sports as well as crime. Also it has book promotion too. We known for our credibity. You can contact us for your querries on our email address. And, If you want to know more about us, then check the relevant pages for this purpose.